{
    "case_number": "CAC-UDRP-101065",
    "time_of_filling": "2015-09-15 11:58:00",
    "domain_names": [
        "BOEHRINGER-INGELHEIM.XYZ"
    ],
    "case_administrator": "Lada Válková (Case admin)",
    "complainant": [
        "BOEHRINGER Ingelheim Pharma GmbH & Co. KG"
    ],
    "complainant_representative": "Nameshield (Laurent Becker)",
    "respondent": [
        "DOMAIN"
    ],
    "respondent_representative": null,
    "factual_background": "FACTS ASSERTED BY THE COMPLAINANT AND NOT CONTESTED BY THE RESPONDENT:\r\n\r\nThe Complainant is a member of a group of companies founded in 1885.  It is a global research-driven pharmaceutical enterprise engaged in human pharmaceuticals and animal health. In 2013, group net sales amounted to about EUR 14.1 billion.\r\n\r\nThe Complainant owns a portfolio of brands including the word “Boehringer” and “Boehringer Ingleheim” in several countries.\r\n\r\nThe Domain Name was registered by the Respondent on August 14th, 2015. It resolves to a single-page website headed BOEHRINGER-INGELHEIM.XYZ IS FOR SALE and seeking \"Your offer\" in US dollars.",
    "other_legal_proceedings": "None of which the Panel is aware.",
    "no_response_filed": "NO ADMINISTRATIVELY COMPLIANT RESPONSE HAS BEEN FILED.",
    "rights": "The Complainant has, to the satisfaction of the Panel, shown the Domain Name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i)of the Policy).",
    "no_rights_or_legitimate_interests": "The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the Domain Name (within the meaning of paragraph 4(a)(ii)of the Policy).",
    "bad_faith": "The Complainant has, to the satisfaction of the Panel, shown the Domain Name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii)of the Policy).",
    "procedural_factors": "The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision. In particular, the Panel is satisfied that the CAC has discharged its responsibility under § 2(a) of the Rules in effect as of July 31, 2015 to employ reasonably available means calculated to achieve actual notice of the Complaint to Respondent.",
    "decision": "Accepted",
    "panelists": [
        "Alan Limbury"
    ],
    "date_of_panel_decision": "2015-10-19 00:00:00",
    "informal_english_translation": "The Complainant has numerous registered trademarks, including International trademark No. 221544 “Boehringer-Ingleheim”, registered on July 2, 1959.",
    "decision_domains": {
        "BOEHRINGER-INGELHEIM.XYZ": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}